NAMS Competitors & Alternatives
Compare NewAmsterdam Pharma Company N.V. Ordinary Shares with similar stocks in the same industry
Biotechnology
NAMS
Main Stock$36.99
Tradestie Score
58
Market Cap
$3.31B
Revenue Growth
0.0%
Analyst Upside
+34.3%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$140.85
|
$3.98B | - | 66 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$83.53
|
$3.92B | - | 40 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$119.24
|
$3.91B | - | 56 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$19.35
|
$3.83B | - | 58 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$18.68
|
$3.68B | - | 57 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$128.31
|
$3.67B | - | 56 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$9.21
|
$3.59B | 13.5 | 57 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$26.20
|
$3.58B | 11.7 | 59 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$319.43
|
$3.49B | 41.8 | 57 | Compare |
More NAMS Analysis
Data updated: Jul 08, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry